Skip to search.
 BSE Up 0.52% NSE Up 0.37%
Streaming
Ticker Tape: On

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
34.17 Down 1.03(2.93%) 7:12PM - Nasdaq Real Time Price
Add to Portfolio
Prev Close:35.20
Open:N/A
Bid:35.56 x 500
Ask:37.23 x 100
1y Target Est:53.78
Beta:1.58
Earnings Date:5 May - 9 May (Est.)
Day's Range:34.17 - 35.89
52wk Range:18.27 - 62.66
Volume:103,544
Avg Vol (3m):1,948,080
Market Cap:4.01B
P/E (ttm):N/A
EPS (ttm):-0.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISISDown 2.93%4.01B
ENZUp 1.17%184.80M
GILDDown 0.77%112.74B
SRPTDown 3.33%1.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):28.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.67
Quarterly EPS Est (Mar-14) :-0.21
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-2.40

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback